期刊文献+

运动对绝经后骨质疏松症影响的实验研究进展 被引量:5

Advances in experimental study of movement on postmenopausal osteoporosis
在线阅读 下载PDF
导出
摘要 随着我国跑步进入老龄化社会,绝经后妇女骨质疏松患病率增加已成为一个重要的公共健康问题。绝经后妇女体内雌激素急剧下降导致骨微环境紊乱,骨吸收大于骨形成,形成高转换型骨代谢。运动已被证实对其有积极的作用。但由于目前诊疗标准不统一、治疗方法不规范、疗效标准欠客观等问题,对于运动方式、强度、运动时间的选择及运动的可替代性国内外学者尚无统一的认识。笔者通过对近年来运动干预绝经后骨质疏松的实验研究的文献进行整理,分析运动防治方法的具体方式、强度与持续时间,提出尚存在的问题和今后的研究方向。 With the fastest-aging society of China, the prevalence of postmenopausal osteoporosis(PMOP) increases year by year, and has gradually become a serious social problem affecting the public health of older-women.The levels of estrogen in post-menopausal women drop obviously, which results in the bone micro-environment disorder, micro-structural damage, absorption greater than osteogenesis, and ultimately forming a high turnover state of bone metabolism. Exercise therapy has been proven to have a positive effect on PMOP, but due to the disunity of diagnostic criteria, the irregularities of treatment methods and the less objectivity of efficacy criteria, domestic and foreign researchers have not yet reached a consensus on the selection of exercise pattern, intensity and time, as well as the substitutability of it with drugs. We organized the experimental study of exercise interventions in ovariectomized rats in recent years, analyzed the effect and underlying molecular mechanism, and then compared different influence of exercise pattern, intensity and time, so as to provide the mechanism and methods evidence for the exercise therapy in clinical prevention and treatment of PMOP.
出处 《海南医学》 CAS 2015年第1期86-89,共4页 Hainan Medical Journal
基金 江苏高校研究生实践创新计划项目(编号:SJLX_0425)
关键词 运动 卵巢切除 骨质疏松 Movement Ovariectomy Osteoporosis
  • 相关文献

参考文献44

  • 1Faienza MF,Ventura A.Marzano F,et al.Postmenopausal osteopo-rosis:the role of immune system cells[J].Clinical and Developmen-tal Immunology,2013,2013:575936.
  • 2Kanis JA,Mc.Closkey EV,Johansson H,et al.European guidancefor the diagnosis and management of osteoporosis in postmenopaus-al women[J].Osteoporos Int,2013,24:23-57.
  • 3Holloway D.Clinical update on honnone replacement therapy[J].British Jounal of Nurs,2010,19(8):498-504.
  • 4Body JJ,Bergmann P,Boonen S,et al.Evidence-based guidelinesfor the pharmacological treatment of postmenopausal osteoporosis:a consensus document by the Belgian Bone Club[J].Osteoporos Int,2010,21(10):1657-1680.
  • 5Chen WY.Postmenopausal honnone therapy and breast cancer risk:current status and unanswered questions[J].Endocrinol Metab Clin North Am,2011,40(3):509-518.
  • 6Al-Anazi AF,Qureshi VF,Javaid K,et al.Preventive effects of phy-toestrogens against postmenopausal osteoporosis as compared tothe available therapeutic choices:Au overview[J].Nat Sci Biol Med,2011,2(2):154-163.
  • 7Bergmann P5 Body JJ,Boonen S,et al.Loading and skeletal devel-opment and maintenance[J].Journal of Osteoporosis,2010,2011:786752.
  • 8Lelovas PP,Xanftios TT,Thoma SE,et al.The laboratory rat as ananimal model for osteoporosis research[J].Comparative Medicine,2008,58(5):424-430.
  • 9Clarke BL,Khosla S.Female reproductive system and bone[J].Arch Biochem Biophys,2010,503(1):118-128.
  • 10Cleemann L,Hjerrild BE,Lauridsen AL,et al.Long-term hormonereplacement therapy preserves bone mineral density in Turner syn-drome[J].Eur J Endocrinol,2009,161(2):251-257.

二级参考文献264

共引文献94

同被引文献96

引证文献5

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部